7 Recruiting Neuroendocrine Tumors Interventional Protocol Clinical Trials
Active interventional protocol studies for neuroendocrine tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Neuroendocrine Tumors studiesInterventional Protocol Studies for Neuroendocrine Tumors
🔵 Active, Not Recruiting Interventional Protocol
Post-Authorization Long-Term Safety Study of LUTATHERA
📍 Banner MD Anderson Cancer Center — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol
Neuroendocrine Tumors - Patient Reported Outcomes
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol
DOTATOC PET/CT for Imaging NET Patients
📍 BC Cancer — Vancouver, British Columbia
View Study & Checklist ➔ 🟡 Not Yet Recruiting Interventional Protocol
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
📍 Clinical Research Institute at Methodist Health System — Dallas, Texas
View Study & Checklist ➔